Sensory Motor Arousal Regulation Treatment (SMART) Study (SMART)
PTSD, Post-traumatic Stress Disorder
About this trial
This is an interventional treatment trial for PTSD focused on measuring PTSD, Post-traumatic Stress Disorder, Body-based trauma therapy, Movement-based trauma therapy, Sensory-motor
Eligibility Criteria
Inclusion Criteria: Adults, aged 18-65 A primary diagnosis of PTSD as determined by our pre-treatment assessment Ability to provide informed consent Fluency in written and spoken English (to be able to complete assessments) Exclusion Criteria: any implants, conditions, etc. that do not comply with 7T (Tesla) fMRI research safety standards (e.g., pacemaker, pregnancy/possible pregnancy) history of significant head injury/lengthy loss of consciousness (e.g., a Glasgow Coma Scale Score < 15 at the time of incident as assessed retrospectively by participant) significant untreated medical illness history of neurological or neurodevelopmental disorder history of any pervasive developmental disorder lifetime bipolar or psychotic disorder alcohol/substance abuse or dependence within the last 3 months extensive narcotic use (e.g., fentanyl, oxycodone, etc.) anyone who would not be suitable for short-term treatment (as determined by our pre-treatment assessment) suicide attempt in last 6 months
Sites / Locations
- London Health Sciences Centre - University Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Active SMART
Wait List
Participants in the active SMART condition will complete 8 individual, 1-hour, weekly sessions of SMART with a therapist, as well as pre-treatment, post-treatment and 3-month follow-up assessments.
Participants in the Wait List condition will receive no treatment for approximately 8 weeks, and they will be asked to complete pre-wait list, post-wait list and 3-month follow-up assessments. After all assessments have been completed, this group will be offered the same 8 individual, 1-hour, weekly sessions of SMART (no further assessments needed).